QR Kod

The Impact of GLP‐1 Receptor Agonists on Esophagogastroduodenoscopy Outcomes: A Retrospective Cohort Study in a Predominantly African American Population

ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) improve glycemic control and promote weight loss but may increase gastric residue, raising concerns during esophagogastroduodenoscopy (EGD). African American patients remain underrepresented in research on these agents. Method...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Ahmed El Sabagh, Ahmad Abdulraheem, Ariel Jimenez, Bara Abujaber, Usman Afzal, Ghaith Almhanni, Kiandokht Bashiri, Islam Badr Ezzeldin Mohamed, Nehal Abdelbaky, Dania Qarkash, Valeria Londono, Anna Stephan, Serenity G. Budd, Alireza Meighani
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley 2026-03-01
Seri Bilgileri:JGH Open
Konular:
African American population
aspiration risk
EGD
endoscopy
GLP‐1 receptor agonists
residual gastric contents
Online Erişim:https://doi.org/10.1002/jgh3.70370
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller